series-a
Stage
2018
Founded
3
Investors
About
VectorY is a gene therapy company developing innovative gene therapies for neurodegenerative diseases. They utilize proprietary AAV-based vectorized antibody platforms to deliver therapeutic proteins to the central nervous system.
Explore VectorY's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.